Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Ur2lurking

opty,

As I understood the bulk of the discussion here was in regards to the new 336 reexamination. That could be in the 584. The application of the law is applied for any given situation. Without looking I will say the examiner has given the reason why, recited the passage in the code and given the number of the code from which it was recited. You only need to Google the code numbers find them. As we discuss the nuances of the process, it would be best to mention the control number of the reexamination to prevent confusion. Moores main patent is the 749. All the other patents are byproducts of that invention. The examiner may have to include prior art in some instances because they are MULTIPLE DEPENDENT CLAIMS.

III. HANDLING OF MULTIPLE DEPENDENT CLAIMS

The following discussion provides guidance on how to treat multiple dependent claims when preparing a reexamination proceeding for publication of the reexamination certificate.

Assume Patent X issues with the following claims:

Patent claims:

http://www.bitlaw.com/source/mpep/2287.html

Share
New Message
Please login to post a reply